Global Cell Culture Instruments and Consumables Market 2017-2022 - Rising Demand for Cell Based Therapies
DUBLIN, October 11, 2017 /PRNewswire/ --
The "Cell Culture Instruments and Consumables Market - Global Opportunity Analysis And Industry Forecasts to 2022" report has been added to Research and Markets' offering.
Global Cell Culture Market is expected to reach USD 21,058 million by 2022, at a CAGR of 10.7% during the forecast period of 2017 to 2022
The global cell culture market is mainly driven by the increase in the life science research, advancement in cell based technology, increasing prevalence of chronic diseases, rising demand for cell based therapies, and increasing cell based production. However, lack of awareness about emerging diagnosis technologies, high cost of cell culture research, and high risk of contamination inhibits the growth of the market to some extent. Moreover, handling and optimization of cell based protocol further challenges the growth of this market.
The large share of this region is primarily attributed to the increased funding in medical research, drug development regulations which demand cell culture products, growing aging population and thereby prevalence of various chronic diseases, and direct & indirect financial investments in the pharma biotech industries.
However, Asia-Pacific region possesses lucrative growth potential for the cell culture market during the forecast period, owing to the increasing demand in China and India, high population zone, various technological advancements, increasing investment in the healthcare and pharmaceutical sector, rising investment from government & non-government bodies, and growing pharma biotech industry in the region.
Market Dynamics
Drivers
- Increasing Life Science Research
- Advancement in Cell Based Technology
- Increasing Prevalence of Chronic Diseases
- Rising Demand for Cell Based Therapies
- Increase in Cell Based Vaccine Production
Restraints
- High Cost of Cell Culture Research
- High Risk of Contamination
Challenge
- Handling and Optimization of Protocol for in Vitro Study
Trend
- Transition from Animal Based Diagnosis to in Vitro Cell Based Diagnosis
Key Topics Covered:
1. Introduction
1.1. Market Ecosystem
1.2. Currency and Limitations
1.2.1. Currency
1.2.2. Limitations
1.3. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation
3. Executive Summary
4. Market Insights
4.1. Introduction
4.2. Drivers
4.2.1. Increasing Life Science Research
4.2.2. Advancement in Cell Based Technology
4.2.3. Increasing Prevalence of Chronic Diseases
4.2.4. Rising Demand for Cell Based Therapies
4.2.5. Increase in Cell Based Vaccine Production
4.3. Restraints
4.3.1. High Cost of Cell Culture Research
4.3.2. High Risk of Contamination
4.4. Challenge
4.4.1. Handling and Optimization of Protocol for in Vitro Study
4.5. Trend
4.5.1. Transition from Animal Based Diagnosis to in Vitro Cell Based Diagnosis
5. Cell Culture Market Size, by Product
5.1. Introduction
5.2. Consumables
5.2.1. Media
5.2.1.1. Classical Media and Salts
5.2.1.2. Natural Media
5.2.1.2.1. Coagulants
5.2.1.2.2. Tissue Extracts
5.2.1.2.3. Biological Fluids
5.2.1.3. Synthetic Media
5.2.1.3.1. Serum Containing Media
5.2.1.3.2. Serum Free Media
5.2.1.3.3. Xeno Free Media
5.2.1.3.4. Protein Free Media
5.2.1.3.5. Chemically Defined Media
5.2.1.4. Specialty Media
5.2.1.5. Stem Cell Media
5.2.2. Sera
5.2.2.1. Fetal Bovine Serum
5.2.2.2. New Born Calf Serum
5.2.2.3. Other Animal Sera
5.2.3. Reagents
5.2.3.1. Antibiotics
5.2.3.2. Attached and Matrix Factors
5.2.3.3. Buffers
5.2.3.4. Subculturing Reagents
5.2.3.5. Cryopreservatives
5.2.3.6. Amino Acids
5.2.3.7. Growth Factors and Cytokines
5.2.3.8. Protease Inhibitors
5.2.3.9. Balanced Salt Solutions
5.2.3.10 Others
5.3. Instruments
5.3.1. Cell Culture Vessels
5.3.1.1. Culture Bags
5.3.1.2. Culture Plates
5.3.1.3. T-Flask
5.3.1.4. Culture Dishes
5.3.1.5. Roller Bottles
5.3.2. Bioreactors
5.3.3. Biosafety Cabinets
5.3.4. Carbon Dioxide Incubators
5.3.5. Centrifuges
5.3.6. Microscopes
5.3.7. Cell Counters
5.3.8. Cryopreservative Tanks
5.3.9. Sterilizers
5.3.10. Pipetting Instruments
6. Cell Culture Market Size, by Application
6.1. Introduction
6.2. Toxicity Testing
6.3. Cancer Research
6.4. Drug Discovery and Development
6.5. Regenerative Medicines
6.6. Vaccination
6.7. Recombinant Products
6.8. Stem Cell Technology
6.9. Others
7. Cell Culture Market Size, by End-User
7.1. Introduction
7.2. Pharmaceutical and Biotechnology Industry
7.3. Academic Institutes
7.4. Research Centers
8. Cell Culture Market Size, by Geography
9. Competitive Landscape
9.1. Introduction
9.2. Partnership and Collaborations
9.3. Mergers and Acquisitions
9.4. New Product Launches and Upgradations
9.5. Expansions
10. Company Profiles
- Agilent Technologies (U.S.)
- American Type Culture Collection (ATCC) (U.S.)
- Becton Dickinson (BD) (U.S.)
- Cell Culture Company (CCC) LLC (U.S.)
- CellGenix GmbH (Germany)
- Corning Incorporation (U.S.)
- GE Healthcare (U.S.)
- HiMedia Laboratories (India)
- Incorporation (U.S.)
- InvivoGen (U.S.)
- Irvine Scientific (U.S.)
- Lonza (Switzerland)
- Merck & Co.
- PromoCell GmbH (Germany)
- Sera Care Life Sciences Incorporation (U.S.)
- Thermo Fisher Scientific (U.S.)
For more information about this report visit https://www.researchandmarkets.com/research/j9hmbt/cell_culture
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article